Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Biocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112538506A details a novel lipase-catalyzed route for Chloramphenicol Succinate, offering higher purity, reduced toxicity, and scalable manufacturing for global supply chains.
Patent CN102586384B reveals a novel deracemization method for D-amino acids using Alcaligenes faecalis, offering high optical purity and simplified downstream processing for pharmaceutical supply chains.
Patent CN109852593B details a high-activity CmCR mutant for R-3HB production, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN108546691A details a novel 7β-HSDH mutant using NADH for cost-effective ursodeoxycholic acid production with high purity and yield.
Patent CN101547893B reveals a novel salt recovery method for biphenylalanine, enabling cost reduction in pharmaceutical intermediate manufacturing through direct extraction and recycling.
Patent CN1100144A details enzymatic resolution for high-purity taxane intermediates, offering cost-effective and scalable pharmaceutical manufacturing solutions.
Novel enzymatic route for S-indoline-2-carboxylic acid ensures >99% ee purity and simplified processing for reliable pharmaceutical intermediate supply chains.
Patent CN113234696B details a novel in vitro enzymatic route for crocetin from zeaxanthin, offering superior purity and scalable production for fine chemical manufacturing.
Patent CN106978368B details a novel nitrilase biocatalysis route for L-glufosinate precursors, offering high optical purity and reduced environmental impact for agrochemical manufacturing.
Novel one-step enzymatic route for L-carnosine reduces cost and complexity. Reliable supply chain partner for high-purity pharmaceutical intermediates and scalable production.
Patent CN110055297B details a novel esterase for resolving (R,S)-5-caprolactone with >98% ee. Discover cost-effective biocatalytic routes for high-purity flavor intermediates.
Patent CN116848257A enables green production of (R)-mandelic acid. Achieve cost reduction in pharmaceutical intermediates manufacturing with sustainable enzyme cascades.
Patent CN1754963A details a solvent-free enzymatic route for pyroglutamic acid esters, offering high purity and cost-effective manufacturing for personal care suppliers.
Novel enzymatic method for L-2-aminobutyric acid production. Low cost, high yield, scalable process for pharmaceutical intermediates and supply chain optimization.
Patent CN114592027A reveals a novel two-step method for Tauroursodeoxycholic Acid production, offering significant cost reduction in API manufacturing and high-purity outcomes.
Novel enzyme mutant technology enables green cordycepin production. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN102250976A reveals an enzymatic route for chiral tert-leucine. Achieve >99% ee and significant cost reduction in pharmaceutical intermediate manufacturing with scalable green chemistry.
Patent CN114214375A details a novel enzymatic route for high-purity Ruxolitinib intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105461606A reveals enzymatic hydrolysis for Ledipasvir intermediates. Achieve >99% de purity and scalable green manufacturing for Hepatitis C drug supply chains.
Patent CN102899367B details a hybrid bio-chemical synthesis for high-purity Tenofovir. This method offers significant cost reduction and scalable manufacturing for API intermediates.